A detailed history of Bay Colony Advisory Group, Inc D transactions in Abbott Laboratories stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 18,345 shares of ABT stock, worth $2.11 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
18,345
Previous 17,224 6.51%
Holding current value
$2.11 Million
Previous $1.79 Million 16.88%
% of portfolio
0.33%
Previous 0.31%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

BUY
$100.07 - $118.13 $112,178 - $132,423
1,121 Added 6.51%
18,345 $2.09 Million
Q2 2024

Jul 24, 2024

BUY
$100.73 - $112.44 $37,270 - $41,602
370 Added 2.2%
17,224 $1.79 Million
Q1 2024

Apr 30, 2024

SELL
$109.52 - $120.96 $13,361 - $14,757
-122 Reduced 0.72%
16,854 $1.92 Million
Q4 2023

Jan 29, 2024

BUY
$90.19 - $110.4 $36,256 - $44,380
402 Added 2.43%
16,976 $1.87 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $40,122 - $48,140
-420 Reduced 2.47%
16,574 $1.61 Million
Q2 2023

Aug 11, 2023

SELL
$100.78 - $112.29 $4,635 - $5,165
-46 Reduced 0.27%
16,994 $1.85 Million
Q1 2023

Apr 27, 2023

SELL
$96.86 - $114.01 $59,278 - $69,774
-612 Reduced 3.47%
17,040 $1.73 Million
Q4 2022

Feb 01, 2023

BUY
$95.06 - $111.52 $42,016 - $49,291
442 Added 2.57%
17,652 $1.94 Million
Q3 2022

Oct 27, 2022

BUY
$96.76 - $112.03 $51,186 - $59,263
529 Added 3.17%
17,210 $1.67 Million
Q2 2022

Aug 08, 2022

BUY
$102.07 - $123.37 $47,972 - $57,983
470 Added 2.9%
16,681 $1.82 Million
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $26,224 - $31,979
-230 Reduced 1.4%
16,211 $1.92 Million
Q4 2021

Jan 28, 2022

SELL
$115.53 - $141.46 $32,694 - $40,033
-283 Reduced 1.69%
16,441 $2.31 Million
Q3 2021

Nov 02, 2021

SELL
$116.66 - $129.06 $6,416 - $7,098
-55 Reduced 0.33%
16,724 $1.98 Million
Q2 2021

Jul 22, 2021

BUY
$105.79 - $124.53 $45,912 - $54,046
434 Added 2.66%
16,779 $1.95 Million
Q1 2021

May 13, 2021

BUY
$108.84 - $128.23 $409,564 - $482,529
3,763 Added 29.91%
16,345 $1.96 Million
Q4 2020

Feb 02, 2021

BUY
$105.0 - $114.42 $172,200 - $187,648
1,640 Added 14.99%
12,582 $1.38 Million
Q3 2020

Nov 25, 2020

BUY
$91.64 - $111.29 $22,635 - $27,488
247 Added 2.31%
10,942 $1.19 Million
Q2 2020

Jul 23, 2020

SELL
$76.57 - $98.0 $17,151 - $21,952
-224 Reduced 2.05%
10,695 $978,000
Q1 2020

Apr 17, 2020

SELL
$62.82 - $91.86 $16,019 - $23,424
-255 Reduced 2.28%
10,919 $862,000
Q4 2019

Jan 28, 2020

SELL
$78.51 - $87.4 $14,838 - $16,518
-189 Reduced 3.77%
4,823 $419,000
Q4 2019

Jan 28, 2020

BUY
$78.51 - $87.4 $498,617 - $555,077
6,351 Added 131.68%
11,174 $1.03 Million
Q3 2019

Oct 25, 2019

BUY
$81.84 - $88.74 $410,182 - $444,764
5,012 New
5,012 $419,000
Q1 2019

Apr 30, 2019

SELL
$66.22 - $80.06 $447,183 - $540,645
-6,753 Closed
0 $0
Q4 2018

Jan 29, 2019

BUY
$65.56 - $74.27 $72,771 - $82,439
1,110 Added 19.67%
6,753 $488,000
Q3 2018

Nov 05, 2018

BUY
$60.81 - $73.36 $275,590 - $332,467
4,532 Added 407.92%
5,643 $414,000
Q2 2018

Aug 09, 2018

BUY
$57.57 - $63.54 $63,960 - $70,592
1,111 New
1,111 $68,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bay Colony Advisory Group, Inc D Portfolio

Follow Bay Colony Advisory Group, Inc D and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.